Logo

Eli Lilly to Acquire Protomer Technologies for ~$1B

Share this

M&A

Eli Lilly to Acquire Protomer Technologies for ~$1B

Shots:

  • Eli Lilly to acquire Protomer Technologies for ~$1B- with the achievement of future development and commercial milestones
  • Earlier- Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment
  • The acquisition will boost Lilly’s diabetes pipeline with the addition of Protomer's glucose-sensing insulin that can sense sugar levels in the blood and automatically activate as needed throughout the day

  Ref: Lilly | Image: Eli Lilly

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions